Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

ClinicalTrials.gov ID: NCT00073021

Public ClinicalTrials.gov record NCT00073021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 10:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, 6-Week, Parallel-Group Design Clinical Trial to Assess Safety and Efficacy of Asacol 4.8 g/Day (800 mg Tablet) Versus Asacol 2.4 g/Day (400 mg Tablet) for the Treatment of Moderately Active Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a prospective clinical study to evaluate the safety and efficacy of two different doses of Asacol for the treatment of moderately active ulcerative colitis. In addition, a new tablet formulation will be evaluated at one of the two doses.

Study identification

NCT ID
NCT00073021
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Warner Chilcott
Industry
Enrollment
386 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2000 (Type not available)
Primary completion
Sep 2003 (Actual)
Completion
Sep 2003 (Actual)
Last update posted
Jun 29, 2015

2000 – 2003

United States locations

U.S. sites
54
U.S. states
25
U.S. cities
50
Facility City State ZIP Site status
Mayo Clinic Scottsdale Scottsdale Arizona 85259 —
AGMG Clinical Research Anaheim California 92801 —
Research Site Los Angeles California 90067 —
Community Clinical Trials Orange California 38305 —
AGMG Clinical Research Orange California 92869 —
Research Site Sacramento California 95825 —
Sharp Rees-Stealy Medical Group San Diego California 92123 —
Research Site Arvada Colorado 80002 —
Research Site Englewood Colorado 80110 —
Center for Medical Research, LLC Manchester Connecticut 06040 —
Center for GI Disorders Hollywood Florida 33021 —
Research Site Maitland Florida 32789 —
Advanced Gastroenterology Associates Palm Harbor Florida 34684 —
Research Site Zephyrhills Florida 33540 —
Southeast Research Associates Marietta Georgia 30067 —
University of Chicago Medical Center Chicago Illinois 60637 —
GI Research Metairie Louisiana 70001 —
Louisiana Research Center Shreveport Louisiana 71103 —
Digestive Disorders Associates Annapolis Maryland 21401 —
Research Site Baltimore Maryland 21215 —
Digestive Disease Associates Baltimore Maryland 21229 —
Metropolitan Gastroenterology Group Chevy Chase Maryland 20815 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
Henry Ford Hospital Detroit Michigan 48202 —
Mayo Clinic Rochester Minnesota 55905 —
PharmaTrials, Inc. Hillsborough New Jersey 08844 —
Research Site Forest Hills New York 11375 —
Long Island Clinical Research Associates Great Neck New York 11021 —
Research Site New York New York 10128 —
Carolinas Digestive Health Associates Charlotte North Carolina 28262 —
Research Site Raleigh North Carolina 27612 —
Research Site Statesville North Carolina 28677 —
Consultants for Clinical Research Cincinnati Ohio 45219 —
Research Site Cincinnati Ohio 45267 —
Research Site Columbus Ohio 43215 —
GI & Liver Consultants Dayton Ohio 45440 —
Research Site Oklahoma City Oklahoma 73190 —
Research Site Tulsa Oklahoma 74135 —
West Hills Gastroenterology Group Portland Oregon 97225 —
Research Site Altoona Pennsylvania 16602 —
Research Site Hanover Pennsylvania 17331 —
Regional Research Institute Jackson Tennessee 38305 —
Research Site Austin Texas 78705 —
Research Site Dallas Texas 75246 —
Research Site Houston Texas 77030 —
Houston Medical Research Associates Houston Texas 77090 —
Research Site Temple Texas 76508 —
Research Site Ogden Utah 84405 —
Charlottesville Medical Research Charlottesville Virginia 22902 —
Research Site Fairfax Virginia 22031 —
Research Site Fredericksburg Virginia 22401 —
Richmond GI Research Richmond Virginia 23226 —
Research Site Spokane Washington 99207 —
Wisconsin Center for Advanced Research Milwaukee Wisconsin 53207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00073021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 29, 2015 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00073021 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →